loadpatents
name:-0.22978901863098
name:-0.033691883087158
name:-0.021392107009888
Bastos; Cecilia M. Patent Filings

Bastos; Cecilia M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bastos; Cecilia M..The latest application filed is for "proteasome activity enhancing compounds".

Company Profile
20.31.38
  • Bastos; Cecilia M. - S. Grafton MA
  • Bastos; Cecilia M. - South Grafton MA
  • Bastos; Cecilia M. - Marlborough MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Proteasome Activity Enhancing Compounds
App 20220298181 - Cullen; Matthew ;   et al.
2022-09-22
Compounds, Compositions, And Methods For Modulating Cftr
App 20220227739 - Munoz; Benito ;   et al.
2022-07-21
Methods Of Treating Pulmonary Diseases And Disorders
App 20220175735 - Miller; John ;   et al.
2022-06-09
Compounds, compositions, and methods for modulating CFTR
Grant 11,248,010 - Munoz , et al. February 15, 2
2022-02-15
Proteasome activity enhancing compounds
Grant 11,242,361 - Cullen , et al. February 8, 2
2022-02-08
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20210369749 - Parks; Daniel ;   et al.
2021-12-02
Compounds, compositions, and methods for modulating CFTR
Grant 11,136,313 - Munoz , et al. October 5, 2
2021-10-05
Compounds, compositions, and methods for increasing CFTR activity
Grant 11,098,035 - Bastos , et al. August 24, 2
2021-08-24
Compounds, compositions, and methods of increasing CFTR activity
Grant 11,083,709 - Munoz , et al. August 10, 2
2021-08-10
Proteasome Activity Enhancing Compounds
App 20210115057 - Cullen; Matthew ;   et al.
2021-04-22
Compounds, Compositions, And Methods For Modulating Cftr
App 20210061823 - Munoz; Benito ;   et al.
2021-03-04
Compounds, compositions, and methods for increasing CFTR activity
Grant 10,899,751 - Parks , et al. January 26, 2
2021-01-26
Compounds, Compositions, And Methods For Modulating Cftr
App 20200385365 - Munoz; Benito ;   et al.
2020-12-10
Compounds, Compositions, And Methods Of Increasing Cftr Activity
App 20200360348 - Munoz; Benito ;   et al.
2020-11-19
Proteasome Activity Enhancing Compounds
App 20200308198 - Cullen; Matthew ;   et al.
2020-10-01
Compounds, compositions, and methods for increasing CFTR activity
Grant 10,738,040 - Bastos , et al. A
2020-08-11
Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
Grant 10,738,011 - Bastos , et al. A
2020-08-11
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20200190072 - Bastos; Cecilia M. ;   et al.
2020-06-18
Compounds, compositions, and methods for modulating CFTR
Grant 10,662,207 - Munoz , et al.
2020-05-26
Compounds, compositions, and methods for modulating CFTR
Grant 10,550,106 - Munoz , et al. Fe
2020-02-04
Compounds, compositions, and methods of increasing CFTR activity
Grant 10,548,878 - Munoz , et al. Fe
2020-02-04
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20200010461 - Parks; Daniel ;   et al.
2020-01-09
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20190308960 - Bastos; Cecilia M. ;   et al.
2019-10-10
Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
Grant 10,392,378 - Bastos , et al. A
2019-08-27
Compounds, compositions, and methods for increasing CFTR activity
Grant 10,392,372 - Bastos , et al. A
2019-08-27
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
Grant 10,344,023 - Bastos , et al. July 9, 2
2019-07-09
Compounds, Compositions, And Methods For Modulating Cftr
App 20190153000 - Munoz; Benito ;   et al.
2019-05-23
Compounds, compositions, and methods for increasing CFTR activity
Grant 10,174,014 - Bastos , et al. J
2019-01-08
Methods Of Treating Pulmonary Diseases And Disorders
App 20180369209 - Miller; John ;   et al.
2018-12-27
Derivatives Of 5-(hetero)arylpyrazol-3-carboxylic Amide Or 1-(hetero)aryltriazol-4-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis
App 20180327363 - Bastos; Cecilia M. ;   et al.
2018-11-15
Compounds, Compositions, And Methods For Modulating Cftr
App 20180291006 - Munoz; Benito ;   et al.
2018-10-11
Proteasome Activity Enhancing Compounds
App 20180282352 - Cullen; Matthew ;   et al.
2018-10-04
Compounds, Compositions, And Methods Of Increasing Cftr Activity
App 20180214419 - Munoz; Benito ;   et al.
2018-08-02
Compounds, compositions, and methods for increasing CFTR activity
Grant 10,017,503 - Bastos , et al. July 10, 2
2018-07-10
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20180147187 - Bastos; Cecilia M. ;   et al.
2018-05-31
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20180127400 - Bastos; Cecilia M. ;   et al.
2018-05-10
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors
App 20180093981 - Siegel; Craig ;   et al.
2018-04-05
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20170369480 - Bastos; Cecilia M. ;   et al.
2017-12-28
Derivatives Of 5-phenyl- Or 5-heteroarylathiazol-2-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis
App 20170369482 - Bastos; Cecilia M. ;   et al.
2017-12-28
Proteasome activity enhancing compounds
Grant 9,850,262 - Cullen , et al. December 26, 2
2017-12-26
Derivatives Of 3-heteroarylisoxazol-5-carboxylic Amide Useful For The Treatment Of Inter Alia Cystic Fibrosis
App 20170362214 - Bastos; Cecilia M. ;   et al.
2017-12-21
Compounds, compositions, and methods for increasing CFTR activity
Grant 9,790,219 - Bastos , et al. October 17, 2
2017-10-17
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
Grant 9,744,153 - Siegel , et al. August 29, 2
2017-08-29
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
Grant 9,745,294 - Siegel , et al. August 29, 2
2017-08-29
Compounds, compositions, and methods for increasing CFTR activity
Grant 9,745,292 - Bastos , et al. August 29, 2
2017-08-29
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20170233379 - Bastos; Cecilia M. ;   et al.
2017-08-17
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20170001993 - Bastos; Cecilia M. ;   et al.
2017-01-05
Compounds, Compositions, And Methods For Increasing Cftr Activity
App 20170001991 - Bastos; Cecilia M. ;   et al.
2017-01-05
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors
App 20160338996 - Siegel; Craig ;   et al.
2016-11-24
Proteasome Activity Enhancing Compounds
App 20160333031 - Cullen; Matthew ;   et al.
2016-11-17
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
Grant 9,272,996 - Siegel , et al. March 1, 2
2016-03-01
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors
App 20150225393 - Siegel; Craig ;   et al.
2015-08-13
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
Grant 8,940,776 - Siegel , et al. January 27, 2
2015-01-27
2-acylaminopropoanol-type Glucosylceramide Synthase Inhibitors
App 20120322786 - Siegel; Craig ;   et al.
2012-12-20
2-acylaminopropoanol-type Glucosylceramide Synthase Inhibitors
App 20120322787 - Siegel; Craig ;   et al.
2012-12-20
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
Grant 8,309,593 - Siegel , et al. November 13, 2
2012-11-13
2-acylaminopropoanol-type glucosylceramide synthase inhibitors
Grant 8,304,447 - Siegel , et al. November 6, 2
2012-11-06
2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors
App 20110184021 - Siegel; Craig ;   et al.
2011-07-28
2-acylaminopropoanol-type Glucosylceramide Synthase Inhibitors
App 20100256216 - Siegel; Craig ;   et al.
2010-10-07
Phosphate transport inhibitors
Grant 7,754,200 - Jozefiak , et al. July 13, 2
2010-07-13
Phosphate transport inhibitors
App 20070021509 - Jozefiak; Thomas H. ;   et al.
2007-01-25
Phosphate transport inhibitors
App 20060280719 - Jozefiak; Thomas H. ;   et al.
2006-12-14
Phosphate transport inhibitors
Grant 7,119,120 - Jozefiak , et al. October 10, 2
2006-10-10
Phosphate transport inhibitors
Grant 7,109,184 - Jozefiak , et al. September 19, 2
2006-09-19
Phosphate transport inhibitors
App 20040019113 - Jozefiak, Thomas H. ;   et al.
2004-01-29
Phosphate transport inhibitors
App 20040019020 - Jozefiak, Thomas H. ;   et al.
2004-01-29
Method for inhibiting immune response
Grant 5,708,022 - Bastos , et al. January 13, 1
1998-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed